Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fang-Ji-Di-Huang-Decoction (FJDH) is a classical Traditional Chinese Medicine (TCM) formula first documented in the *Synopsis of the Golden Chamber* (Jin Gui Yao Lue) during the Eastern Han Dynasty. It is a multi-herbal preparation consisting of the dried roots of *Rehmannia glutinosa*, *Stephania tetrandra*, *Saposhnikovia divaricata*, and *Glycyrrhiza uralensis*, along with the dried twigs of *Cinnamomum cassia*. Traditionally used to clear heat, remove dampness, and nourish blood, modern pharmacological research has explored its potential in treating psoriasis. The decoction appears to work by inhibiting the IL-23/Th17 inflammatory axis, thereby reducing the secretion of pro-inflammatory cytokines such as IL-17A, IL-17F, IL-22, and TNF-α. A notable aspect of its preparation is the traditional use of copperware, which facilitates the formation of bioactive complexes between *Rehmannia glutinosa* polysaccharides and copper ions, significantly enhancing the formula's therapeutic efficacy in suppressing skin inflammation and keratinocyte proliferation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fang-Ji-Di-Huang-Decoction.